BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Crucell N.V. 

Archimedesweg 4
P.O. Box 2048
CA Leiden    2301  The Netherlands
Phone: 31-0-71-524-8701 Fax: 31-0-71-524-8702


SEARCH JOBS


Industry
Biotechnology






 Company News
Mucosis B.V. Signs Research and License Option Agreement With Crucell N.V. (CRXL) 10/8/2012 10:44:12 AM    More...
CLC bio Delivers Specialized Antibody Engineering and Selection Software for Crucell N.V. (CRXL) 6/8/2012 9:33:51 AM    More...
ARTES Biotechnology Announces a Strategic Collaboration Deal for Vaccine Development 4/24/2012 9:54:26 AM    More...
Judgment Issued in Crucell N.V. (CRXL) Buy-Out Proceedings 2/28/2012 9:02:25 AM    More...
Crucell N.V. (CRXL) Release: Promising Results of Novel Combination Vaccine 1/5/2012 11:09:37 AM    More...
Crucell N.V. (CRXL) Discovers Important New Antibody Against Influenza A 7/8/2011 9:28:26 AM    More...
Isconova Enters into Adjuvant License Agreement with Crucell N.V. (CRXL) 6/9/2011 9:25:39 AM    More...
Crucell N.V. (CRXL), GlaxoSmithKline (GSK) And PATH MVI Partner to Develop Second-Generation Vaccine Against Malaria 6/7/2011 7:54:15 AM    More...
Crucell N.V. (CRXL) Intends to Delist Ordinary Shares on NYSE Euronext 3/15/2011 8:10:01 AM    More...
Johnson & Johnson (JNJ) Acquires 98.89% of Crucell N.V. (CRXL) Shares 3/9/2011 6:45:08 AM    More...
12345678910...

//-->